Association Between Different Hemoglobin A1c Levels and Clinical Outcomes Among Elderly Nursing Home Residents With Type 2 Diabetes Mellitus

Journal of the American Medical Directors Association

Volumn 15, Issue 10, 2014, Pages 757-762

  Davis, Keith L ^a   Wei, Wenhui ^b   Meyers, Juliana L ^a   Kilpatrick, Brett S ^c   Pandya, Naushira ^d  

^a RTI HEALTH SOLUTIONS   (United States)

^b SANOFI   (France)

^c AnalytiCare   (United States)

^d affiliation with Nova Southeastern College of Osteopathic Medicine   (United States)

Author keywords

Elderly; Hemoglobin A1c; Long term care; Type 2 diabetes mellitus

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA GLUCOSIDASE INHIBITOR; DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLUCAGON LIKE PEPTIDE 1 DERIVATIVE; HEMOGLOBIN A1C; INSULIN; MEGLITINIDE; METFORMIN; SULFONYLUREA; ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN;

AGED; ARTICLE; COMORBIDITY; DIABETIC KETOACIDOSIS; EMERGENCY WARD; FALLING; FEMALE; GERIATRIC PATIENT; GLYCEMIC CONTROL; GROUPS BY AGE; HOSPITALIZATION; HUMAN; HYPOGLYCEMIA; INFECTION; INFECTION RATE; INSULIN TREATMENT; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NON INSULIN DEPENDENT DIABETES MELLITUS; NURSING HOME; NURSING HOME PATIENT; OUTCOME ASSESSMENT; UNITED STATES; VERY ELDERLY; BLOOD; CROSS-SECTIONAL STUDY; DIABETES MELLITUS, TYPE 2; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; UNITED STATES;

EID: 84927691612     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2014.06.007     Document Type: Article

References (20)

1. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011 2011, Centers for Disease Control and Prevention, US Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA, Available at:, Accessed January 23, 2014. http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf.
2. Resnick H.E., Heineman J., Stone R., Shorr R.I. Diabetes in US nursing homes, 2004. Diabetes Care 2008, 31:287-288.
3. Narayan K.M., Boyle J.P., Geiss L.S., et al. Impact of recent increase in incidence on future diabetes burden: US, 2005-2050. Diabetes Care 2006, 29:2114-2116.
4. Inzucchi S.E., Bergenstal R.M., Buse J.B., et al. Management of hyperglycemia in type 2 diabetes: A patient-centered approach: Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012, 35:1364-1379.
5. Kirkman M.S., Briscoe V.J., Clark N., et al. Diabetes in older adults. Diabetes Care 2012, 35:2650-2664.
6. Meneilly G.S., Cheung E., Tuokko H. Counterregulatory hormone responses to hypoglycemia in the elderly patient with diabetes. Diabetes 1994, 43:403-410.
7. Fravel M.A., McDanel D.L., Ross M.B., et al. Special considerations for treatment of type 2 diabetes mellitus in the elderly. Am J Health Syst Pharm 2011, 68:500-509.
8. Mallery L.H., Ransom T., Steeves B., et al. Evidence-informed guidelines for treating frail older adults with type 2 diabetes: From the Diabetes Care Program of Nova Scotia (DCPNS) and the Palliative and Therapeutic Harmonization (PATH) program. JAm Med Dir Assoc 2013, 14:801-808.
9. Sinclair A., Morley J.E., Rodriguez-Mañas L., et al. Diabetes mellitus in older people: Position statement on behalf of the International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Task Force of Experts in Diabetes. JAm Med Dir Assoc 2012, 13:497-502.
10. Huang E.S., Liu J.Y., Moffet H.H., et al. Glycemic control, complications, and death in older diabetic patients: The diabetes and aging study. Diabetes Care 2011, 34:1329-1336.
11. Kodl C.T., Seaquist E.R. Cognitive dysfunction and diabetes mellitus. Endocr Rev 2008, 29:494-511.
12. Chen L.K., Chen Y.M., Lin M.H., et al. Care of elderly patients with diabetes mellitus: A focus on frailty. Ageing Res Rev 2010, 9:S18-S22.
13. Amati F., Dubé J.J., Coen P.M., et al. Physical inactivity and obesity underlie the insulin resistance of aging. Diabetes Care 2009, 32:1547-1549.
14. Gerstein H.C., Miller M.E., et al. Effects of intensive glucose lowering in type 2 diabetes. NEngl J Med 2008, 358:2545-2559. Action to Control Cardiovascular Risk in Diabetes Study Group.
15. Patel A., MacMahon S., et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. NEngl J Med 2008, 358:2560-2572. ADVANCE Collaborative Group.
16. Duckworth W., Abraira C., Moritz T., et al. Glucose control and vascular complications in veterans with type 2 diabetes. NEngl J Med 2009, 360:129-139.
17. Duckworth W.C., Abraira C., Moritz T.E., et al. The duration of diabetes affects the response to intensive glucose control in type 2 subjects: The VA Diabetes Trial. JDiabetes Complications 2011, 25:355-361.
18. Currie C.J., Peters J.R., Tynan A., et al. Survival as a function of HbA(1c) in people with type 2 diabetes: A retrospective cohort study. Lancet 2010, 375:481-489.
19. Centers for Disease Control and Prevention. Diabetes Data and Trends. Available at: . Accessed January 23,2014. http://apps.nccd.cdc.gov/DDTSTRS/default.aspx.
20. Clement S., Braithwaite S.S., Magee M.F., et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care 2004, 27:553-591.